سعر اوبلونج فارمالجين 500مجم 10 اقراص 2025

Arab Drug Company Oblong Pharmalgin 500 mg tablets, pack of 10; metamizole (dipyrone).

• Severe pain and fever that cannot be controlled with other treatments (authorised uses vary between EU countries)European Medicines Agency (EMA)

• Agranulocytosis (sudden sharp fall in granulocytes that can lead to serious or fatal infections) is listed as a rare or very rare side effect (frequency not known in some products).International label, same formulation · European Medicines Agency (EMA)

• Previous agranulocytosis induced by metamizole or other pyrazolones/pyrazolidines; impaired bone marrow function or diseases of the haematopoietic system.International label, same formulation · European Medicines Agency (EMA)

• Agranulocytosis is a known, non-dose-dependent adverse effect that can occur at any time during treatment or shortly after stopping, even after previous uneventful use. Patients must stop treatment and seek immediate medical attention if fever, chills, sore throat or painful mucosal sores develop.International label, same formulation · European Medicines Agency (EMA)
• When metamizole is taken for fever, or with antibiotics, early symptoms of agranulocytosis may be masked.International label, same formulation · European Medicines Agency (EMA)
• Metamizole is associated with agranulocytosis and other blood dyscrasias; use only when justified; contraindicated after prior metamizole-induced blood disorders.General active-ingredient information · European Medicines Agency (EMA)

• Evidence in pregnancy is scarce; little suggests problems in early pregnancy and single doses in the first 6 months might be acceptable if other analgesics cannot be used.International label, same formulation · European Medicines Agency (EMA)
• Should not be used during breastfeeding because the infant may receive high amounts in milk relative to body weight.International label, same formulation · European Medicines Agency (EMA)

English text not available for this section.